We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other ...

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...

January 29, 2025, 1:30 PM ESTCommercial Real Estate January 17, 2025, 5:27 AM ESTHealth Care January 14, 2025, 3:50 PM ESTHealth Care January 12, 2025, 4:36 PM ESTHealth Care January 09, 2025, 6: ...

Moderna (NASDAQ:MRNA) shares about 3% ahead of Wednesday market open after Goldman Sachs cut its rating on the stock to Neutral from Buy.

Referring to the biotech’s RSV vaccine, the panel said, “Moderna had, in effect, made a payment to a U.K. health professional to attend a promotional meeting which detailed an investigational ...

The inquiry will also hear from Nadhim Zahawi and representatives of Moderna Biotech UK and NHS England. Ms Badenoch, now the Tory leader, will be asked questions about her time as the equalities ...

Moderna secures a multi-year agreement to supply its COVID-19 vaccine to 17 European countries, including Norway and North Macedonia. Vaccine formats include prefilled syringes, reducing ...

Moderna (NASDAQ:MRNA ... The Cambridge, Massachusetts-based biotech's personalized cancer vaccine mRNA-4157, developed with Merck (MRK), is currently in late-stage development targeting patients ...

Biotechnology company Moderna (NASDAQ:MRNA) gained the spotlight in the medical sector as a leader in the race toward a COVID-19 vaccine. Its messenger RNA (mRNA) technology garnered acclaim as a ...

A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu. The biotech firm's mRNA-1018 candidate posted positive ...